Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
11,490,488
Share change
+3,599,459
Total reported value
$19,549,099
Put/Call ratio
3365%
Price per share
$1.70
Number of holders
41
Value change
+$5,927,577
Number of buys
19
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q1 2020

As of 31 Mar 2020, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,490,488 shares. The largest 10 holders included RTW INVESTMENTS, LP, Carmignac Gestion, VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GROUP ONE TRADING, L.P., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and FIRST MANHATTAN CO. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.